表紙
市場調査レポート

世界の白内障手術向け眼内レンズ(IOL)市場:市場シェア・戦略・予測

Intraocular Lens (IOL) for Cataract Surgery: Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2018

発行 WinterGreen Research, Inc. 商品コード 261626
出版日 ページ情報 英文 293 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
世界の白内障手術向け眼内レンズ(IOL)市場:市場シェア・戦略・予測 Intraocular Lens (IOL) for Cataract Surgery: Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2018
出版日: 2013年02月11日 ページ情報: 英文 293 Pages
概要

世界の眼内レンズ(IOL)市場額は2019年までに38億米ドルに達すると予測されています。2010年の白内障手術数は1900万件、2012年に1970万件となりました。白内障は世界の失明のうち48%を占めています。白内障は可逆性失明の主な原因となっています。

当レポートでは、世界の眼内レンズ(IOL)市場について調査分析し、市場概要、市場の促進因子、市場課題、市場シェア、市場予測、および主要企業のプロファイルなどをまとめ、概略下記の構成にてお届けいたします。

エグゼクティブサマリー

第1章 眼内レンズ:市場概要・市場力学

  • 白内障手術市場は急速に発展
  • 変貌を遂げようとしている世界経済

第2章 眼内レンズ市場シェア・予測

  • 眼内レンズ:市場推進因子
  • 眼内レンズ市場シェア
  • 眼内レンズ市場予測
  • 眼内レンズ価格
  • 眼内レンズの地域別市場

第3章 眼内レンズ製品概要

  • IOLレンズ
  • Novartis / Alcon
  • Abbott Medical Optics / Visiogenの Synchrony
  • Bausch & Lomb / Crystalens
  • Calhoun Visionの調光レンズ
  • NuLens
  • PixelOptics
  • Imperial Medical Technologies
  • PresbiaのFlexivue
  • LenstecのTetraflex Lens
  • Staar
  • LxenstecのTetraflex
  • Hoya
  • Tecnis MF
  • Oculentis のMPlus
  • PhysIOLの FineVision
  • WaveTec Vision
  • 小児白内障 / 眼内レンズ (IOL)

第4章 IOL技術

  • 人間の目
  • 白内障
  • 眼圧技術
  • 非球面コンタクトレンズ
  • 屈折障害
  • トーリック眼内レンズ(乱視矯正用眼内レンズ)の研究
  • 外科医は適切な患者選択に集中する必要
  • Mayo Clinic の眼内レンズの長期転位の研究

第5章 主要企業プロファイル

図表

目次
Product Code: SH25463732

Worldwide markets are poised to achieve continuing growth as the aging population worldwide develops cataracts and need Intraocular Lenses (IOL). All older people develop cataracts.

Cataracts are a clouding of the eye's natural lens that impairs one's ability to see clearly. With two accommodating Intraocular Lens IOLs likely to be approved within the next 12 months, the premium market is again exciting.

Intraocular lens market driving forces include the aging of the population. With age, all people have cataracts which can be cured with IOL. There is an ever-increasing baby boom aging population. There is a growing precision of cataract surgery. Safety of cataract surgical medical devices and lenses are primary market concerns. More advanced procedures are driving an increase in cataract surgery. Lower costs per surgery are driving an increase in cataract surgery.

Cataract surgical technology is evolving rapidly. Premium intraocular lenses (IOLs) introduced during the past decade and those still in the pipeline are raising patient's post-cataract visual expectations. Laser-assisted cataract surgery technology is gaining traction with clinicians. Surgeons are getting trained in the techniques needed to perform surgeries these new types of equipment. The motivation to learn the new surgical techniques is that the equipment comes with the promise of improved surgical precision.

As a result, growing needs and expectations for good vision in all ranges have created significant new market opportunities, expanding demand for multifocal and accommodating IOLs designed to correct presbyopia, aspheric optics that address spherical aberration and make vision sharper, and phakic IOLs allowing treatment of extreme refractive error.

Ultrasonic phacoemulsification, the standard of care in cataract removal equipment for four decades, has been in great part responsible for the safety and effectiveness of modern cataract surgery. It is certain to remain the dominant lens removal technology in the near term. A technology still in its infancy, laser-assisted cataract surgery using femtosecond lasers and picosecond lasers, promises to raise the standard of precision and safety to new heights.

Numerous types, and styles of Intraocular Lenses (IOLs), varying in size, and attachment mechanisms. The femtosecond lasers may evolve capability to fix the cataract without implanting an IOL devices, creating a significant change in the market after the forecast period.

The eye care industry is highly competitive and subject to rapid technological change and evolving industry requirements and standards. Companies within this industry compete on technological leadership and innovation, quality and efficacy of their products, relationships with eye care professionals and healthcare providers, breadth and depth of product offering and pricing. The presence of these factors varies across regions.

In the United States, the leading market segment, an aging population, the affluence of the American "baby boomer" generation, and the ability of surgeons to bill for a premium refractive outcome will drive significant growth in this lens-based refractive surgery sector.

Intraocular Lens (IOL) markets are driven by the trend towards multi-distance vision capability, near middle, and far. The global market is expected to post a modest growth. The global market for Intraocular Lenses (IOL) total market value is expected to reach $3.8 billion by 2019.

The global intraocular lens cataract market is expanding with the aging of a more affluent middle class population. There were 19 million cataract surgeries in 2010 and 19.7 million in 2012. Cataracts account for 48% of world blindness. Cataracts are the leading cause of reversible blindness.

Table of Contents

Executive Summary

The study is designed to give a comprehensive overview of the Intraocular Lens equipment market segment. Research represents a selection from the mountains of data available of the most relevant and cogent market materials, with selections made by the most senior analysts. Commentary on every aspect of the market from independent analysts creates an independent perspective in the evaluation of the market. In this manner the study presents a comprehensive overview of what is going on in this market, assisting managers with designing market strategy likely to succeed.

INTRAOCULAR LENS (IOL) EXECUTIVE SUMMARY

  • Intraocular Lens Market Driving Forces
  • Cataract Surgical Technology Is Evolving Rapidly
  • Patient Populations Have Significant Demand for Cataract Surgery
  • Challenge To Get Wide Acceptance Of A New Lens Once It Is Approved
  • Cataract Surgery Business
  • Intraocular Lens Market Challenges
  • World Population Growth
  • Intraocular Lens Market Shares
  • Intraocular Lens Market Forecasts

Intraocular LensMarket Description and Market Dynamics

1. INTRAOCULAR LENS MARKET DESCRIPTION AND MARKET DYNAMICS

  • 1.1 Cataract Surgical Technology Is Evolving Rapidly
    • 1.1.1 Patient Populations Have Significant Demand for Cataract Surgery
    • 1.1.2 Challenge To Get Wide Acceptance Of A New Lens Once It Is Approved
    • 1.1.3 Cataract Surgery Business
    • 1.1.4 Intraocular Lens Market Challenges
  • 1.2 World Economy Undergoing A Transformation
    • 1.2.1 Global Economic Conditions:
    • 1.2.2 Global Economy Becomes Steadily More Sluggish
    • 1.2.3 Global Economic Conditions Impact Markets

Intraocular LensMarket Shares and Market Forecasts

This section selectively describes market shares, forecasts, segments, and regional revenue. Numbers are the result of primary research in all cases. Selected company are described from an independent analyst perspective with a thumbnail sketch or analysis of their market numbers or commentary on their strengths and weaknesses. Some of the analysis is focused on looking at the topic segment by segment, including company descriptive analyses by segment and subsegment.

2. INTRAOCULAR LENS MARKET SHARES AND FORECASTS

  • 2.1 Intraocular Lens Market Driving Forces
    • 2.1.1 Cataract Surgical Technology Is Evolving Rapidly
    • 2.1.2 Patient Populations Have Significant Demand for Cataract Surgery
    • 2.1.3 Challenge To Get Wide Acceptance Of A New Lens Once It Is Approved
    • 2.1.4 Cataract Surgery Business
    • 2.1.5 Intraocular Lens Market Challenges
    • 2.1.6 World Population Growth
  • 2.2 Intraocular Lens Market Shares
    • 2.2.1 Novartis / Alcon
    • 2.2.2 Novartis / Alcon Competitive Situation
    • 2.2.3 Novartis / Alcon Competition
    • 2.2.4 Novartis Alcon Multifocal Lenses
    • 2.2.5 Novartis / Alcon
    • 2.2.6 Novartis / Alcon
    • 2.2.7 Novartis / Alcon AcrySof® Toric Intraocular Lens - (IOL) - FDA Approval P930014/S045
    • 2.2.8 LenSx Acquired by Alcon
    • 2.2.9 Abbott Medical Optics
    • 2.2.10 Abbott Medical Optics / Visiogen's Synchrony
    • 2.2.11 Abbott Tecnis
    • 2.2.12 Abbott TECNIS® IOLs
    • 2.2.13 Bausch & Lomb Presbyopic IOLs
    • 2.2.14 Bausch + Lomb
    • 2.2.15 Bausch + Lomb Eye Surgical Technologies In The Pipeline
    • 2.2.16 Bausch + Lomb: Accommodating IOLs
    • 2.2.17 Bausch + Lomb: Crystalens IOL
    • 2.2.18 OptiMedica
    • 2.2.19 Staar Acrylic IOL
    • 2.2.20 Staar
    • 2.2.21 Staar Silicone IOLs
    • 2.2.22 Staar® Surgical Company nanoFLEX IOL
    • 2.2.23 Staar Visian
    • 2.2.24 LensAR
    • 2.2.25 PhysIOL's FineVision
    • 2.2.26 IOL Research and New Lenses
    • 2.2.27 ReSTOR Multifocal Toric AcrySof IQ
    • 2.2.28 Abbott Tecnis One-Piece Toric
    • 2.2.29 Lenstec Tetraflex
    • 2.2.30 Calhoun Vision Light-Adjustable Lens
    • 2.2.31 Abbott Visiogen Synchrony
    • 2.2.32 Rayner M-flex T
    • 2.2.33 NuLens DynaCurv
    • 2.2.34 Carl Zeiss AcriLisa Diffractive Multifocal Toric
    • 2.2.35 Bausch + Lomb's Crystalens Toric
    • 2.2.36 Hoya's Adoptics
  • 2.3 Intraocular Lens Market Forecasts
    • 2.3.1 Intraocular Lens Market Segment Forecasts
    • 2.3.2 Number of Cataract Surgeries Per Year
    • 2.3.3 Novartis Positioning with Sales and Marketing Resource
    • 2.3.4 Bausch + Lomb Small Incisions
    • 2.3.5 Femtosecond Technology Is Game Changer
    • 2.3.6 Intraocular Lens Unit Analysis
    • 2.3.7 Aspheric Foldable IOL Lens
    • 2.3.8 Intraocular Lens Presbyopia Market Forecasts
    • 2.3.9 Market Trend: Monofocal IOL Channel Will Be Slowly But Continuously Eroded By The Multifocal IOL
    • 2.3.10 Presbyopia-Correcting Intraocular Lens (IOL)
    • 2.3.11 Premium Channel Surgeons
    • 2.3.12 Market Trend: Accommodating IOL Channel to Grow
    • 2.3.13 Market Trends: Diffractive Lenses
    • 2.3.14 Market Trend: Multifocal IOLs
    • 2.3.15 Market Trend: Surgical Workstation
    • 2.3.16 Premium IOL Forecasts
    • 2.3.17 Technologies Driving Intraocular Lens IOL Market Growth
    • 2.3.18 Diffractive IOLs
    • 2.3.19 Large Middleclass Population Base Driving Intraocular Lens IOL Market Growth
    • 2.3.20 Nonfoldable Polymethylmethacrylate/Plexiglas Based Lenses To Silicone And Acrylic Based Foldable Lenses
    • 2.3.21 Global Vision Care and Ocular Market
  • 2.4 Intraocular Lens Prices
    • 2.4.1 Premium Lens Technology Reimbursement Trends
    • 2.4.2 CMS Medicare Intorocular Reimbursement Guidelines
  • 2.5 Intraocular Lens Regional Market
    • 2.5.1 Eye Surgical Techniques by Country
    • 2.5.2 United States
    • 2.5.3 Canada
    • 2.5.4 Brazil Cataract Surgical Procedure
    • 2.5.5 Brazilian Cataract surgeries
    • 2.5.6 China 2-68
    • 2.5.7 Toric Lens Implantations On The Rise In Europe
    • 2.5.8 Advanced Technology Intraocular Lens Growth Markets
    • 2.5.9 Cataract Surgery in the UK
    • 2.5.10 Asia-Pacific Cataract Surgery
    • 2.5.11 Cataract Surgery in India
    • 2.5.12 Cataract Surgery Assembly Line System Followed At Aravind Eye Hospitals
    • 2.5.13 Aurolab's Low-Cost, High-Volume Business Model
    • 2.5.14 Highly Efficient Operations Coupled With Pricing Structure Allow 50% Profit Margin
    • 2.5.15 World Health Organization (WHO),

Intraocular Lens Product Description

This section describes selected company and selected products. Products for this market segment are described with attention to the most significant aspect of features and functions in this category of product. The juxtaposition of a range of different product descriptions from a single market category provides a really good way to access market directions and achieve market competitive analysis. This section is arranged in three pieces: immersive products, conference room products, and end point products. Company products are described in the appropriate sections, meaning a company is mentioned several times in the chapter in different places.

3. INTRAOCULAR LENS (IOL) PRODUCT DESCRIPTION

  • 3.1 IOL lenses
  • 3.2 Novartis / Alcon
    • 2.1.1 Novartis / Alcon
    • 2.1.2 Novartis / Alcon Competitive Situation
    • 2.1.3 Novartis / Alcon Competition
    • 2.1.4 Novartis Alcon Multifocal Lenses
    • 2.1.5 Novartis / Alcon
    • 2.1.6 Novartis / Alcon
    • 2.1.7 Novartis / Alcon AcrySof® Toric Intraocular Lens - (IOL) - FDA Approval P930014/S045
    • 2.1.8 LenSx Acquired by Alcon
  • 3.3 Abbott Medical Optics / Visiogen's Synchrony
    • 3.3.1 Abbott Medical Optics Synchrony
    • 3.3.2 Abbott Medical Optics'
    • 3.3.3 Abbott Medical Optics / Visiogen's Synchrony Lens
  • 3.4 Bausch & Lomb / Crystalens
    • 3.4.1 Bausch & Lomb Crystalens AO Lens
    • 3.4.2 Bausch + Lomb: Accommodating IOLs
    • 3.4.3 Bausch + Lomb: Crystalens IOL
    • 3.4.4 Bausch & Lomb Crystalens HD
  • 3.5 Calhoun Vision's Light Adjustable Lens
  • 3.6 NuLens
  • 3.7 PixelOptics
  • 3.8 Imperial Medical Technologies'
  • 3.9 Presbia's Flexivue
  • 3.10 Lenstec's Tetraflex Lens
  • 3.11 Staar
    • 3.11.1 STAAR® Surgical Company nanoFLEX IOL
    • 3.11.2 Staar Elastimide® Silicone Aspheric IOL
    • 3.11.3 Staar nanoFLEX™ Collamer Aspheric Single-Piece IOL
    • 3.11.4 Staar Afinity™ Collamer® Aspheric IOL
    • 3.11.5 STAAR Toric™ IOL
    • 3.11.6 Staar Afinity™ and nanoFLEX™ Collamer Aspheric IOLs
    • 3.11.7 Staar Collamer Advantage
    • 3.11.8 Staar nanoFLEX™ Collamer Aspheric Single-Piece IOL
    • 3.11.9 STAAR Surgical Elastimide Silicone Aspheric IOL Model AQ2015A
    • 3.11.10 STAAR Elastimide Lens Model AQ2003V
    • 3.11.11 STAAR Elastimide Lens Model AQ2010V
    • 3.11.12 STAAR Elastimide Lens Model AQ5010V - Low Diopter
    • 3.11.13 STAAR Elastimide Lens Model AQ2017V (Discontinued)
    • 3.11.14 STAAR Elastimide Lens Model AQ1016V (Discontinued)
    • 3.11.15 STAAR Elastic Lens Model AA4204VF
    • 3.11.16 STAAR Elastic Lens Model AA4204VL
    • 3.11.17 STAAR Elastic Lens Model AA4207VF (Discontinued)
    • 3.11.18 STAAR Toric Silicone Single Piece IOL
    • 3.11.19 STAAR Elastic Toric Lens Model AA4203TL
    • 3.11.20 Canon-STAAR Preloaded IOL Model KS-3Ai
  • 3.12 Lxenstec's Tetraflex
    • 3.12.1 Lxenstec's Tetraflex Manufactured To A Tenth Of A Diopter Toleranc3-e
    • 3.12.2 Lxenstec Elenza Lens
  • 3.13 Hoya
  • 3.14 Tecnis MF
    • 3.14.1 PowerVision (Belmont, Calif.), Oculentis (Berlin), and PhysIOL (Liége, Belgium
    • 3.14.2 PowerVision's FluidVision
    • 3.14.3 FluidVision
  • 3.15 MPlus by Oculentis
  • 3.16 PhysIOL's FineVision
  • 3.17 WaveTec Vision
  • 3.18 Pediatric Cataract / Intraocular Lenses (IOL)
    • 3.18.1 4 D change in power is needed between ages 10 and 20
    • 3.18.2 Correcting Astigmatism in Pediatric Patients

Intraocular Lens Technology

4. INTRAOCULAR LENS (IOL) TECHNOLOGY

  • 4.1 The Human Eye
  • 4.2 Cataracts
    • 4.2.1 Staar Collamer
    • 4.2.2 Cataract Symptoms
    • 4.2.3 Benefits Of Cataract Eye Surgery
    • 4.2.4 How Cataract Eye Surgery Is Performed
  • 4.3 Intraocular Tens Technology
    • 4.3.1 Technologies Driving Intraocular Lens IOL Market Growth
  • 4.4 Aspheric Contact Lenses
  • 4.5 Refractive Disorders
  • 4.6 Studies On The Restor Toric Lens
    • 4.6.1 MNRead Functional Reading Test
  • 4.7 Surgeons Need To Concentrate On Proper Patient Selection
  • 4.8 Mayo Clinic Study of Long-Term Dislocation Of Intraocular Lenses
    • 4.8.1 Obesity Cause of Diabetes and Neuropathy of the Eye

Intraocular Lens Company Profiles

This section selectively describes company strategy, partners, acquisitions, and revenue by segment and regional revenue when available. Company are described by looking at what is most interesting about that company. The descriptions collectively give a sense of market directions within the industry segment. The alphabetical listing of company thumbnail sketches provides an accessible way to find out what is going on in any particular company.

5. INTRAOCULAR LENS (IOL) COMPANY DESCRIPTION

  • 5.1 Abbott Laboratories
    • 5.1.1 Abbott Acquired Visiogen with Synchrony Product
    • 5.1.2 Abbott Labs Cataract Company Acquisitions
    • 5.1.3 Abbott Completes Separation of Research-Based Pharmaceuticals Business
    • 5.1.4 Abbott (NYSE: ABT) Separation Of Its Research-Based Pharmaceuticals Business
    • 5.1.5 Abbott Separating Into Two Independent Companies
    • 5.1.6 Abbott Laboratories and Subsidiaries Revenue
    • 5.1.7 Abbott Sales Mix
    • 5.1.8 Abbott Nutritional Market Presence
    • 5.1.9 Abbott Diagnostics Market Presence
    • 5.1.10 Abbott Medical Devices Market Presence
    • 5.1.11 Abbott Strength Through Ability to Innovate
    • 5.1.12 Abbott Revenue
    • 5.1.13 Abbott Medical Optics
    • 5.1.14 Abbott Medical Optics Corneal Products
    • 5.1.15 Abbott Medical Optics Refractive Product Line
    • 5.1.16 Abbott Medical Optics Cataract Products
    • 5.1.17 Abbott Medical Optics Technological Innovation
  • 5.2 Akkolens
    • 5.2.1 AkkoLens Features
    • 5.2.2 AkkoLens Clinical Partners
  • 5.3 Allergan
    • 5.3.1 Allergan Flagship Franchises In Eye Care, Neurosciences, Medical Dermatology And Urologics
    • 5.3.2 Allergan Acquisition of Inamed Corporation
    • 5.3.3 Allergan Specialty Product Lines Focused On High-Growth Markets
    • 5.3.4 Allergan Global in reach. Specialized in focus
    • 5.3.5 Allergan Leading Products
    • 5.3.6 Allergan/ SkinMedica, Inc. Acquisition
    • 5.3.7 Allergan Obesity Intervention
  • 5.4 Aravind
    • 5.4.1 Future of Aravind
  • 5.5 Bausch And Lomb
    • 5.5.1 Bausch + Lomb Vision Care
    • 5.5.2 Bausch + Lomb Pharmaceuticals
    • 5.5.3 Bausch + Lomb Cataract and Vitreoretinal Surgery
    • 5.5.4 Bausch + Lomb to Acquire Technolas Perfect Vision GmbH
    • 5.5.5 Bausch + Lomb Technolas® Perfect Vision
    • 5.5.6 Bausch + Lomb Technolas® Perfect Vision Transforming Refractive Surgery
    • 5.5.7 Bausch + Lomb to Acquire Technolas Perfect Vision GmbH
    • 5.5.8 Technolas Perfect Vision
  • 5.6 Biovision
  • 5.7 Elenza
  • 5.8 Kowa Company, Ltd. Environmental & Energy Saving Products
  • 5.9 Hoya
    • 5.9.1 Hoya, Seiko And Epson; Agreements Executed In The Field Of Optical Products Business
    • 5.9.2 Hoya Second Quarter Revenue
  • 5.10 Lenstec
  • 5.11 Novartis Group / Alcon
    • 5.11.1 Novartis Alcon Division
    • 5.11.2 Novartis Revenue
    • 5.11.3 Alcon Cataract Surgery
    • 5.11.4 Alcon Surgical Glaucoma
    • 5.11.5 Alcon Vitreoretinal
    • 5.11.6 Alcon Refractive Surgery
    • 5.11.7 Alcon Acquires Leading Ocular Surgical Guidance Technology
    • 5.11.8 Alcon
    • 5.11.9 Alcon Acquired The Ophthalmic Division of SensoMotoric Instruments (SMI)
    • 5.11.10 Alcon Division Surgical Products
    • 5.11.11 Alcon Ophthalmic Pharmaceuticals
    • 5.11.12 Alcon Products
    • 5.11.13 Alcon Cataract Reimbursement
    • 5.11.14 Alcon Regulation
    • 5.11.15 LenSx Acquired by Alcon
  • 5.12 OptiMedica
    • 5.12.1 Catalys next generation laser cataract surgery platform
  • 5.13 Physiol 5-56
    • 5.13.1 Physiol Multifocal IOL FineVision (Micro F) 2
  • 5.14 Rayner 5-57
    • 5.14.1 Surgery on 109 Year old Woman Using Rayner IOL
  • 5.15 Staar Surgical
    • 5.15.1 STAAR Surgical Devices Used In Corrective Surgery
    • 5.15.2 STAAR Surgical Minimally Invasive Intraocular Lenses (IOLs).
  • 5.16 WaveTec Vision®
    • 5.16.1 WaveTec Vision Secures $16.5m To Market Cataract Surgery System
  • 5.17 Zeiss - 5-68
    • 5.17.1 Zeiss Vision
    • 5.17.2 Zeiss Revenue
  • 5.18 Selected Companies in the Market

List of Tables and Figures

Intraocular Lens Executive Summary

  • Table ES-1 Intraocular Lens Market Driving Forces
  • Figure ES-2 Advanced Technology Intraocular Lens Growth Drivers
  • Table ES-2 Cataract Surgery Diverse Market Growth Drivers Several generations of IOLs have created significant technical advances in the market. Intraocular Lens market challenges are evolving in the context of this dramatic market shift.
  • Table ES-3 Intraocular Lens Market Challenges
  • Table ES-4 Intraocular Lens (IOL) Market Shares, Dollars, Worldwide, 2012
  • Figure ES-5 Intraocular Lens (IOL) Market Forecasts, Dollars, Worldwide, 2013-2019

Intraocular Lens Market Description and Market Dynamics

  • Table 1-1 Cataract Surgery Diverse Market Growth Drivers
  • Table 1-2 Intraocular Lens Market Challenges

Intraocular Lens Market Shares and Market Forecasts

  • Table 2-1 Intraocular Lens Market Driving Forces
  • Figure 2-2 Advanced Technology Intraocular Lens Growth Drivers
  • Table 2-2 Cataract Surgery Diverse Market Growth Drivers Several generations of IOLs have created significant technical advances in the market. Intraocular Lens market challenges are evolving in the context of this dramatic market shift
  • Table 2-3 Intraocular Lens Market Challenges
  • Table 2-4 Intraocular Lens (IOL) Market Shares, Dollars, Worldwide, 2012
  • Table 2-5 Intraocular Lens (IOL) Market Shares, Dollars, Worldwide, 2012
  • Table 2-6 Novartis Cataract Surgical Techniques
  • Figure 2-7 Novartis / Alcon Overview of Surgical Franchise
  • Figure 2-8 Alcon Key Intraocular Lenses (IOLs) Products
  • Table 2-9 Novartis / Alcon IOL Market Strategic Positioning
  • Figure 2-10 Bausch + Lomb Crystalens® is an FDA-approved intraocular lens
  • Table 2-11 ReSTOR's Acrylic Material Helps Keep It From Rotating Postop
  • Figure 2-12 Abbott Tecnis Toric IOL
  • Figure 2-13 Lenstec Tetraflex
  • Figure 2-14 Abbott Visiogen Synchrony
  • Figure 2-15 NuLens DynaCurv
  • Figure 2-16 Intraocular Lens (IOL) Market Forecasts, Dollars, Worldwide, 2013-2019
  • Table 2-17 Intraocular Lens Market Forecasts Units and Dollars, Worldwide, 2013-2019
  • Figure 2-18 Low End Intraocular Lens (IOL) Market Shipments Forecasts Dollars, Worldwide, 2013-2019
  • Figure 2-19 Premium Intraocular Lens (IOL) Market Shipments Forecasts Dollars, Worldwide, 2013-2019
  • Table 2-20 Intraocular Lens (IOL) Market Forecasts Units and Dollars, Worldwide, 2013-2019
  • Figure 2-21 Intraocular Lens (IOL), Market Forecasts, Units, Worldwide, 2013-2019
  • Figure 2-22 Novartis Franchise Dedicated Resources
  • Figure 2-23 Cataract Surgery Pathophysiology, Prevalence, and Surgical Techniques
  • Table 2-24 Intraocular Lens Description
  • Table 2-25 Intraocular Lens Advanced Technology
  • Figure 2-26 Novartis Commentary on Cataracts as Leading Cause of Reversible Blindness
  • Figure 2-27 Intraocular Lens (IOL) Regional Market Segments, Dollars, 2012
  • Table 2-28 Intraocular Lens (IOL) Regional Market Revenue Segments, US and Worldwide, Dollars, Worldwide, 2013-2019
  • Table 2-29 Intraocular Lens (IOL) Regional Market Revenue Segments, US and Worldwide Percent, Worldwide, 2013-2019
  • Figure 2-30 Eye Surgical Techniques by Country

Intraocular Lens Product Description

  • Figure 3-1 Novartis / Alcon Key Intraocular Lenses (IOLs) Products
  • Table 3-2 Novartis Cataract Surgical Techniques
  • Figure 3-3 Novartis / Alcon Overview of Surgical Franchise
  • Table 3-4 Novartis / Alcon IOL Market Strategic Positioning
  • Table 3-5 Abbott Medical Optics Cataract Products
  • Table 3-6 Abbott Medical Visiogen's Synchrony lens Advantages
  • Table 3-7 Abbott Medical Visiogen's Synchrony Lens Disadvantages
  • Figure 3-8 Bausch + Lomb Crystalens® FDA-Approved Intraocular Lens
  • Figure 3-9 Bausch + Lomb: Crystalens IOL Features
  • Figure 3-10 STAAR® Surgical Company nanoFLEX IOL
  • Figure 3-11 Staar Implantable Collamer® Lens for Quality of Vision
  • Table 3-12 Staar IOL Products
  • Figure 3-12 Staar Toric Visual Acuity
  • Figure 3-13 Hoya Pre-Loaded IOL Delivery System "iSert™

Intraocular Lens Technology

  • Figure 4-1 Human Eye
  • Figure 4-2 Staar nanoFLEX
  • Figure 4-3 Staar nanoFLEX Collamer has a built in Anti-Reflective Interface
  • Figure 4-4 Staar Hydrophilic Collamer Ultra-High Water Content Layer On Its Surface Minimizing The Difference In Refractive Index
  • Figure 4-5 Staar nanoFLEX™ Collamer Percentage of Light Reflectance
  • Figure 4-6 Staar nanoFLEX™ Collamer Single Piece IOL
  • Figure 4-7 Staar nanoFLEX™ Collamer Incision Size
  • Figure 4-8 Staar nanoFLEX™ Collamer Protective Layer
  • Figure 4-9 Staar Afinity 3-Piece Collamer Aspheric IOL Model CQ2015A Function 4-10 Modulation Transfer Function (MTF) Analysis
  • Table 4-11 Cataract Symptoms

Intraocular Lens Company Profiles

  • Table 5-1 AkkoLens Technological Features
  • Table 5-2 AkkoLens Medical Features
  • Figure 5-3 Hoya IOL plant in Singapore
  • Figure 5-4 Novartis / Alcon Positioning in Healthcare
  • Figure 5-5 Novartis Resource By Segment
  • Figure 5-6 Novartis Surgical Franchise
Back to Top